Aprogen Biologics Inc. (KRX:003060)

Aprogen Biologics Revenue

Aprogen Biologics had revenue of 21.62B KRW in the quarter ending March 31, 2026, with 28.33% growth. This brings the company's revenue in the last twelve months to 78.00B, up 13.67% year-over-year. In the year 2025, Aprogen Biologics had annual revenue of 73.23B with 8.68% growth.

• Revenue (ttm): 78.00B
• Revenue Growth: +13.67%
• P/S Ratio: 0.43
• Revenue / Employee: 199.48M
• Employees: 391
• Market Cap: 33.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	73.23B	5.85B	8.68%
Dec 31, 2024	67.38B	-19.99B	-22.88%
Dec 31, 2023	87.36B	22.17B	34.01%
Dec 31, 2022	65.19B	8.71B	15.42%
Dec 31, 2021	56.48B	3.16B	5.93%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error